Remifemin plus Coated tablets, dry extract of St. John s Wort and Cimicifuga rhizome

Similar documents
Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. CYPROSTAT 50 mg tablet cyproterone acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Read all of this leaflet carefully before you start taking this medicine.

PATIENT INFORMATION LEAFLET TEXAMER

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

Read all of this leaflet carefully before you start taking this medicine.

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

Sibelium 5 mg Tablets flunarizine

Package leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

XYZAL 5 MG FILM-COATED TABLET

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

What is in this leaflet

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

Package leaflet: Information for the user. ANDROCUR 50 mg tablet cyproterone acetate

Package leaflet: Information for the user

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

Dulcolax 5 mg, film-coated tablets

Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride

Package leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the patient

Day Valerian Root Extract Hops Extract. Read all of this leaflet carefully because it contains important information for you.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

PACKAGE LEAFLET. Page 1 of 6

Package leaflet: Information for the user. Anastrozole Teva 1 mg Film-coated Tablets Anastrozole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Aspecton Cough Syrup. Thyme soft extract. For adults and children aged 1 year and older

Package leaflet: Information for the user. Exemestane 25 mg coated tablets exemestane

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the user

PACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride)

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

1. What Solpadol is and what it is used for

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

Package leaflet: Information for the user. Sebivo 600 mg film-coated tablets Telbivudine

PACKAGE LEAFLET: INFORMATION FOR THE USER. RIBOKSĪNS 200 mg film- coated tablets Inosinum

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

Package Leaflet: Information for the user. Anti-Hist Allergy 10mg Film-Coated Tablets. Cetirizine dihydrochloride

Motens 2 mg and 4 mg Tablets lacidipine

2 What you need to know before you take Naramig

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

2 What you need to know before you take Zantac

Transcription:

Package leaflet: information for the user Remifemin plus Coated tablets, dry extract of St. John s Wort and Cimicifuga rhizome Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take Remifemin plus carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must contact a doctor if your symptoms worsen or do not improve after 4 to 6 weeks. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What Remifemin plus is and what it is used for 2. Before you take Remifemin plus 3. How to take Remifemin plus 4. Possible side effects 5. How to store Remifemin plus 6. Further information 1. What Remifemin plus is and what it is used for Remifemin plus is a herbal medicine to relieve menopausal complaints. Remifemin plus is used to relieve the menopausal complaints (climacteric) such as: hot flushes, sweating, depressive moods and psychovegetative disturbances such as dejection, inner tension, irritability, lack of concentration, insomnia, anxiety and/or nervous restlessness, premenstrual psychovegetative disorders. 2. Before you take Remifemin plus Do not take Remifemin plus if you are concomitantly treated with another medicine containing one of the following medicinal agents or a medicinal agent of one of the following substance groups: Medicine for suppression of transplant rejections - ciclosporin - tacrolimus for internal use - sirolimus Medicinal drugs for treatment of HIV-infections or AIDS - proteinase inhibitors such as indinavir - non-nucleosid-reverse-transcriptase-inhibitors such as nevirapin Cytostatics such as - imatinib - irinotecan with the exception of monoclonal antibodies if you are hypersensitive to Cimicifugae rhizome or St. John s Wort or any of the other ingredients of Remifemin plus if you know about existing photohypersensitivity of the skin.

Take special care with Remifemin plus: Medicinal products like Remifemin plus containing St. John's Wort (Hypericum) may interact with other medicinal agents: active substances of Hypericum may accelerate the excretion of other medicinal agents and thus reduce the efficacy of these other substances. As far as a concomitant use of Remifemin plus with other medicinal products is regarded as necessary, your doctor has to consider the possible interactions: Reduction of effects of digoxin, verapamil, simvastatin, midazolam, anticoagulants (phenprocoumon, warfarin). Women taking oral contraceptives should be advised of the possibility of interaction causing intermenstrual bleeding and of the need for additional contraceptive measures, as the reliability of the contraceptive can possibly be reduced. If you experience any menstrual problems or your menstruation reappears. Also if unclear symptoms persist or new symptoms appear you should consult a doctor. This is because they may be evidence of illnesses that require investigation by a doctor. If you take oestrogens concurrently this should be done only under medical supervision. Consult your doctor. If you already have liver injury. Then Remifemin plus should only be taken after consultation with your doctor. If signs and symptoms suggesting a liver injury (yellowing of the skin or eyes, dark urine, upper stomach pain, nausea, loss of appetite, tiredness) occur. You should stop taking Remifemin plus immediately and consult a doctor. if you have been treated or you are undergoing treatment for breast cancer or other hormone-dependent tumours, you should not use Remifemin without medical advice. if the symptoms worsen during the use of Remifemin, you should consult a doctor or a pharmacist. Taking Remifemin plus with other medicines: Remifemin plus may interact with various other medicines in such a way that the concentration of these substances in the blood is reduced and thus possibly their efficacy, too. The following medicinal agents belong to these substances: - anticoagulants (phenprocoumon, warfarin) - digoxin - verapamil - simvastatin - midazolam - hormonal oral contraceptives (occurrence of intermenstrual bleedings) - different agents against depression such as amitriptyline and nortriptyline. In case of simultaneous intake of certain active agents for treatment of depression (trazodone, paroxetine, sertraline) adverse reactions (such as e.g. nausea, vomiting, anxiety, restlessness, confusion) may increasingly occur in single cases. If given simultaneously with other medicines which increase skin photosensitivity, an increase in the phototoxic effects (see section on undesirable effects ) is possible.

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding: There are no adequate data on the use of Remifemin plus during pregnancy and breast-feeding. Remifemin plus should therefore not be taken during pregnancy and breast-feeding. Driving and using machines: There are no special precautions necessary. Important information about some of the ingredients of Remifemin plus: This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 3. How to take Remifemin plus Always take Remifemin plus exactly as directed in this package leaflet. You should check with your doctor or pharmacist if you are not sure. Unless otherwise prescribed, the usual dose is: Take 1 coated tablet twice a day, if necessary 2 coated tablets twice a day. Take the coated tablets in the morning and evening unchewed with some liquid. You can take the coated tablets independently from the meals. Method of administration: Remifemin plus is for oral use. Duration of use: As the results of treatment improve further on prolonged administration, Remifemin plus should be taken over a longer period. In order to avoid overlooking of other illnesses, a doctor should be consulted after 6 months. Please consult your doctor or pharmacist if you have the impression that the effect of Remifemin plus is too strong or too weak. If you take more Remifemin plus than you should: In the event of overdose of Remifemin plus, the listed side effects may increasingly occur. If this happens, you should stop taking the medicine and consult a doctor. If you forget to take Remifemin plus: Do not take a double dose to make up for a forgotten tablet. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, Remifemin plus can cause side effects, although not everybody gets them. Assessment of side effects is based on the following frequency rates: very common: more than 1 treated patient of 10 common: 1 to 10 treated patients of 100 uncommon: 1 to 10 treated patients of 1,000 rare: 1 to 10 treated patients of 10,000

very rare: less than 1 treated patient of 10,000 unknown: Possible side effects: rare: 1 to 10 in 10.000 patients treated very rare: less than 1 in 10,000 treated patients, or unknown frequency not assessable on the basis of the available data - gastrointestinal disorders (upper abdominal disorders, diarrhoea), - allergic skin reactions (urticaria, pruritis, skin rash) - face swelling or peripheral swelling - increase in liver enzymes (transaminases) - weight gain - tiredness or agitation - particularly in light-skinned persons, due to the increased sensitivity of the skin (photosensitisation): sunburn-like reactions in parts of the skin which have been exposed to strong light (sun, solarium). - reports of liver injury during the use of medicines containing Cimicifuga rhizome. No definite causal connection with these medicines has been proved at present. In these cases, you should stop taking the medicine and consult your doctor. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. How to store Remifemin plus Keep out of the reach and sight of children. Do not use the medicine after the expiry date which is stated on the side flap of this pack. The expiry date refers to the last day of that month. Do not store above 25 C! 6. Further information What Remifemin plus contains: The active substances are: 1 coated tablet contains: Hyperici herb. extr. sicc. (dry extract of St. John's Wort) corresponding to total hypericin (standard.) = 0.25 mg and Cimicifugae rhiz. extr. sicc. (dry extract of Black Cohosh) corresponding to triterpene glycosides calculated as 27-Deoxyactein (standard.) = 1.0 mg The other ingredients are: Microcrystalline cellulose, ironoxid E 172, glyceryl behenate, glyceryl alconate, colloidal anhydrous silica, indigotin E 132. potato starch, lactose, macrogol mw=6000, magnesium stearate, methylhydroxypropyl cellulose, talc What Remifemin plus looks like and contents of the pack: Round-convex, dark-green- coloured coated tablets

Remifemin plus is available in packs containing 60, 100 and 120 coated tablets. Marketing authorisation holder and manufacturer Schaper & Brümmer GmbH & Co. KG Bahnhofstraße 35 38259 Salzgitter Germany Tel: (0 53 41) 3 07-0 Fax: (0 53 41) 3 07-124 info@schaper-bruemmer.de http://www.schaper-bruemmer.com This leaflet was last revised in: April 2012.